Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises EQT on its EUR 890 million sale of Dellner Couplers to Wabtec
Mandate

Vinge advises EQT on its EUR 890 million sale of Dellner Couplers to Wabtec

March 19, 2025 M&A

Vinge together with Milbank advises the EQT VIII fund (“EQT”) on its sale of Dellner Couplers (“Dellner”), a leading provider of train connection systems for passenger rail, to Wabtec Corporation (a fortune 500 company listed on the New York Stock Exchange, NYSE: WAB). The transaction values Dellner at approximately EUR 890 million. The transaction is subject to customary conditions and regulatory approvals.

Dellner Couplers is a global leader in train connection systems, providing safety-critical components and services to rail manufacturers and operators worldwide. Founded in 1941 in Vika, Sweden, the Company has grown from a family-owned business into one of the most trusted partners of the global rail industry with a strong presence across Europe, North America, and Asia. Its advanced product portfolio includes couplers, gangways, dampers, and aftermarket services, supporting reliable and efficient rail transportation. Dellner has 17 subsidiaries around the world and more than 1,200 employees globally.

EQT was advised by J.P. Morgan Securities Plc, Milbank, Vinge and EY.

Vinge's team primarily consisted of Christina Kokko, Samra Tesser, Linus Adolfsson and Ian Linde.

Read the clients press release here.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025